echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Prepare for 2021 medical insurance negotiations! The price of PCSK9 monoclonal antibody is reduced by 47%

    Prepare for 2021 medical insurance negotiations! The price of PCSK9 monoclonal antibody is reduced by 47%

    • Last Update: 2021-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 15th, the Liaoning Provincial Drug and Medical Consumables Centralized Procurement Network issued a notice that it received an application from Shanghai Pharmaceuticals Holdings Co.


    Aliciyuumab is a PCSK9 monoclonal antibody of Sanofi Pharmaceuticals.


    At present, domestic PCSK9 monoclonal antibody has not been approved.


    Unfortunately, in the 2020 medical insurance catalog adjustment, both Alisiyuumab and Iloyuumab passed the formal review, but ultimately failed to enter the medical insurance through negotiation


    According to the "Medical Insurance Drug Catalog Adjustment Work Plan (Draft for Comment)" issued by the Medical Insurance Bureau, this year, enterprises will submit the drug materials involved in the negotiation in July.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.